zidovudine has been researched along with Escherichia coli Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Baron, SA; Ben Khedher, M; Diene, SM; Peyclit, L; Rolain, JM; Zerrouki, L | 1 |
Jia, Y; Li, R; Liu, Y; Wang, Z; Xiao, X; Yang, K | 1 |
Keith, BR; White, G; Wilson, HR | 1 |
3 other study(ies) available for zidovudine and Escherichia coli Infections
Article | Year |
---|---|
Inactivation of thymidine kinase as a cause of resistance to zidovudine in clinical isolates of Escherichia coli: a phenotypic and genomic study.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genomics; Humans; Microbial Sensitivity Tests; Thymidine Kinase; Zidovudine | 2020 |
Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Expression Regulation, Bacterial; Mice; Microbial Sensitivity Tests; Microbial Viability; Peritonitis; Tetracycline; Tetracycline Resistance; Zidovudine | 2020 |
In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections.
Topics: Ampicillin; Animals; Bacterial Infections; Cattle; Escherichia coli Infections; Female; Gram-Negative Bacteria; Mice; Mice, Inbred BALB C; Pyelonephritis; Salmonella Infections; Trimethoprim; Zidovudine | 1989 |